Literature DB >> 25823507

Evaluation of Blood Alcohol Concentrations after Oral Administration of a Fixed Combination of Thyme Herb and Primrose Root Fluid Extract to Children with Acute Bronchitis.

S Ludwig1, H Stier2, S Weykam3.   

Abstract

BACKGROUND: The application of alcohol-containing medicinal products to children has been a subject of discussion for many years. A safety threshold of 0.125‰ blood alcohol concentration following the administration of a single dose has been recommended by the European Medicines Agency.The aim of this clinical study was to prove the safety of administering a fixed combination of thyme herb and primrose root fluid extract (Bronchicum(®) Elixir) containing 4.9% ethanol.
METHODS: The herbal drug was administered for a period of 7-9 days to 16 children (ages 1-12 years) suffering from acute bronchitis for ≤ 48 h. After 3-5 days, a blood sample was taken 45 min (children ≥ 5 years: also 0 and 90 min) after application of the drug. The efficacy was assessed using the Bronchitis Severity Score. Global efficacy and tolerability were rated by the investigator and patients.
RESULTS: All measured blood ethanol concentrations were below the threshold (mean value after 45 min: 0.0029 ± 0.0057‰ and after 90 min: 0.0051 ± 0.0078‰). The Bronchitis Severity Score decreased from 6.6 ± 1.0 to 0.9 ± 1.6 points. Global efficacy was assessed as "very good" and "good" in 60% (investigator) and 80% (patients) of cases. Global tolerability was rated as "very good" and "good" in more than 90% of cases.
CONCLUSION: In conclusion, oral administration of the drug containing 4.9% ethanol to children (age 1-12 years) demonstrated a favourable risk/benefit ratio of the drug. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25823507     DOI: 10.1055/s-0034-1398543

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  1 in total

Review 1.  Ethanol in herbal medicinal products for children : Data from pediatric studies and pharmacovigilance programs.

Authors:  Olaf Kelber; Barbara Steinhoff; Christian Nauert; Andreas Biller; Martin Adler; Heba Abdel-Aziz; Samuel N Okpanyi; Karen Kraft; Karin Nieber
Journal:  Wien Med Wochenschr       Date:  2016-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.